THYROCARE TECHNOLOGIES share price has zoomed 4% and is presently trading at Rs 668.4.
Meanwhile, the BSE HEALTHCARE index is at 37,235.8 .
Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 2.0%) and J.B.Chemicals (up 1.8%).
MAX HEALTHCARE INSTITUTE (down 2.5%) and METROPOLIS HEALTHCARE (down 1.4%) are among the top losers today.
Over the last one year, THYROCARE TECHNOLOGIES has moved up from Rs 522.1 to Rs 668.4, registering a gain of Rs 146.4 (up 28.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,235.8, registering a gain of 45.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 86.5%), Cadila Healthcare (up 83.5%) and CAPLIN POINT (up 83.3%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,501.6 .
The top gainers among the BSE Sensex today are Infosys (up 1.2%) and HCl Tech. (up 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,133.3 . HDFC LIFE INSURANCE and Tata Motors are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,501.6, registering a gain of 15,586.2 points (up 24.4%).
THYROCARE TECHNOLOGIES net profit grew 43.0% YoY to Rs 174 million for the quarter ended March 2024, compared to a profit of Rs 122 million a year ago. Net sales rose 13.5% to Rs 1,543 million during the period as against Rs 1,359 million in January-March 2023.
For the year ended March 2023, THYROCARE TECHNOLOGIES reported 63.5% decrease in net profit to Rs 644 million compared to net profit of Rs 1,761 million during FY22. Revenue of the company fell 10.6% to Rs 5,267 million during FY23.
The current Price to earnings ratio of THYROCARE TECHNOLOGIES, based on rolling 12 month earnings, stands at 51.2.
Equitymaster requests your view! Post a comment on "THYROCARE TECHNOLOGIES Gains 4%; BSE HEALTHCARE Index Down 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!